BREAKING
Protagonist Therapeutics Jumps 7.0% in Broad Rally 4 hours ago Valaris Limited Drops 6.7% in Broad Selloff 5 hours ago Talos Energy Inc. Drops 6.2% Amid Sector-Wide Selling 5 hours ago Northern Oil and Gas, Inc. Drops 5.2% in Broad Selloff 5 hours ago Bank7 Corp. Tops Q1 Forecasts With $1.25 EPS, 20.2% Above Consensus 6 hours ago JetBlue Airways Corporation Surges 15.1% in Broad Rally 6 hours ago Celanese Corporation Shares Dropping 5.5% 6 hours ago Akamai Technologies, Inc. Shares Dropping 5.3% 6 hours ago Amazon.com, Inc. (AMZN) Jumps 5.2% to $232.68 6 hours ago Boot Barn Holdings, Inc. Shares Jumping 5.2% 6 hours ago Protagonist Therapeutics Jumps 7.0% in Broad Rally 4 hours ago Valaris Limited Drops 6.7% in Broad Selloff 5 hours ago Talos Energy Inc. Drops 6.2% Amid Sector-Wide Selling 5 hours ago Northern Oil and Gas, Inc. Drops 5.2% in Broad Selloff 5 hours ago Bank7 Corp. Tops Q1 Forecasts With $1.25 EPS, 20.2% Above Consensus 6 hours ago JetBlue Airways Corporation Surges 15.1% in Broad Rally 6 hours ago Celanese Corporation Shares Dropping 5.5% 6 hours ago Akamai Technologies, Inc. Shares Dropping 5.3% 6 hours ago Amazon.com, Inc. (AMZN) Jumps 5.2% to $232.68 6 hours ago Boot Barn Holdings, Inc. Shares Jumping 5.2% 6 hours ago
ADVERTISEMENT
ROIV

Roivant Sciences

$ROIV NASDAQ Feb 6, 2026 BMO Q2 2026

Investor Toolbox

Listen to Call

Watch or listen to the earnings call recording.

Open Webcast

Read Transcript

Transcript not yet available.

View Infographic

Infographic not yet available.

Earnings History

View past quarters and earnings trends.

View History

ROIV Coverage

Event Roivant Sciences (ROIV) Sec Form 8K Apr 3, 2026 Event Roivant Sciences (ROIV) Roivant Announces Expansion of Brepocitinib Development Program with New Phase 2b/3 Trial in Lichen Planopilaris (LPP) and Phase 3 Study Results for Batoclimab in Thyroid Eye Disease (TED) Apr 2, 2026 Event Roivant Sciences (ROIV) Priovant Expands Brepocitinib Development Program with New Phase 2b/3 Trial in Lichen Planopilaris (LPP) Apr 2, 2026 Transcript Roivant Sciences (ROIV) Q2 2026 Earnings Call Transcript Mar 10, 2026 News Roivant Reports Q3 Results, Cites Phase 2 Breakthrough and Catalyst-Rich 2026 Feb 6, 2026 News Roivant Sciences Reports Fiscal Third Quarter 2025 Results Amid Robust Pipeline Advancement Feb 6, 2026 Transcript Roivant Sciences (ROIV) Q3 2025 Earnings Call Transcript Jan 22, 2026 Transcript Roivant Sciences (ROIV) Q4 2025 Earnings Call Transcript Jan 22, 2026